Teleflex (TFX) is a medical device manufacturer. Its revenue has been growing at a CAGR of 5.78% and EBITDA has been growing at a CAGR of 6.88% in the last ten years. However, the stock is richly valued compared to its competitors. The company has a few growth drivers in place. Investors are advised to wait for pullbacks to buy the stock.
Teleflex designs and manufactures single-use medical devices used by hospitals and healthcare providers. These devices are used for diagnostic and therapeutic procedures in critical care and surgical applications. The company has